CCL22 and melanoma: In another study, we showed that brain microenvironmental cells including astrocytes expressed and released CCL17 and CCL22 two chemokine ligands of the chemokine receptor CCR4, which is expressed by a subpopulation of melanoma cells with brain‐metastasizing capacity.